Status:

RECRUITING

Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Cardiac Amyloidosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objective of this study is to assess the beneficial effects of three targeted Shiatsu sessions compared to "comfort" Shiatsu on symptoms in patients with severe cardiac amyloidosis. Specifically, ...

Detailed Description

IAmyloidosis leads to a wide range of disorders, including vascular, cardiac, neuropathic, digestive, renal, and others. These impairments significantly affect patients' quality of life, autonomy, and...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years ;
  • Patient with :
  • Transthyretin of genetic origin (TTR) ;
  • Transthyretin of non-mutated origin (WT) ;
  • Light Chain (AL);
  • Membership of a social security scheme, beneficiary or beneficiary's beneficiary (excluding AME);
  • Written patient consent.
  • Score greater than or equal to 3 on the EESE-R questionnaire (Edmonton Symptom Evaluation Scale-Revised), for at least 1 symptom among: dyspnea, digestive disorders, nausea, pain, anxiety, depression (Shiatsu and non-Shiatsu groups);
  • Score global à l'EESE-R supérieur ou égal à 10 (groupes Shiatsu et sans shiatsu).

Exclusion

  • Patients with orthostatic hypotension;
  • Patients with bullous amyloidosis (fragile skin);
  • Patients who have already received Shiatsu treatment;
  • Patient with insufficient autonomy to maintain sitting position;
  • Patient with insufficient autonomy to move from home to hospital;
  • Participating in another interventional study, or within the exclusion period of a previous study, if applicable;
  • Known pregnancy or breast-feeding;
  • Patient under known guardianship at the time of inclusion;
  • Patient under AME.

Key Trial Info

Start Date :

March 12 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2025

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT06197165

Start Date

March 12 2024

End Date

October 1 2025

Last Update

February 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, France, 94010